NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 315 filers reported holding NEOGENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,251,000 | -29.3% | 126,479 | -0.7% | 0.00% | -40.0% |
| Q3 2021 | $6,013,000 | +7.6% | 127,317 | +2.5% | 0.01% | 0.0% |
| Q2 2021 | $5,588,000 | -17.6% | 124,166 | -11.9% | 0.01% | -16.7% |
| Q1 2021 | $6,780,000 | +9.1% | 140,864 | +21.7% | 0.01% | 0.0% |
| Q4 2020 | $6,216,000 | +82.4% | 115,750 | +24.9% | 0.01% | +50.0% |
| Q3 2020 | $3,407,000 | +19.5% | 92,650 | +0.4% | 0.00% | 0.0% |
| Q2 2020 | $2,850,000 | +145.7% | 92,300 | +119.8% | 0.00% | +100.0% |
| Q1 2020 | $1,160,000 | -5.6% | 42,000 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $1,229,000 | +53.1% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $803,000 | – | 42,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |